COMPARISON OF INTRATHECAL HYPERBARIC ROPIVACAINE 0.5% WITH AND WITHOUT 75 MG MAGNESIUM SULFATE AS AN ADJUVANT FOR INFRA UMBILICAL SURGERIES: A DOUBLE-BLIND RANDOMIZED CLINICAL TRIAL
Keywords:Intrathecal magnesium sulfate, Intrathecal hyperbaric ropivacaine, Day care anesthesia
Objective: Intrathecal magnesium as an adjuvant to hyperbaric ropivacaine could extend duration of sensory blockade and improve the quality of post-operative analgesia; thereby reducing opioid requirements and its adverse effects. Hence, we conducted this prospective, randomized, double-blind clinical trial to observe its effects for day care surgeries.
Methods: After obtaining institutional ethical committee approval and registration of trial, patients’ informed consent was taken and eighty adult patients of either gender, ASA 1 and 2, posted for infra umbilical surgeries were divided into two groups: Group RM received 3 ml hyperbaric Ropivacaine with 0.75 ml magnesium sulfate (75 mg) and Group R received 3 ml hyperbaric Ropivacaine with 0.75 ml sterile water. Sensory and motor blockade parameters, hemodynamic variables, and adverse effects were monitored, analyzed using appropriate statistical tests.
Results: Total duration of sensory blockade was significantly prolonged in Group RM compared to Group R (242.8 ± 9.9 versus 186.6 ± 8.4 min) (***p<0.001). Complete motor regression was observed significantly earlier in Group RM than in Group R (151.3 ± 7.8 versus 184.7 ± 5.6 min) (*p<0.05). Post-operative pain free interval was significantly prolonged in group RM compared to group R (725.2 ± 18.6 vs. 515.2 ± 17.8 min) (***p<0.001).
Conclusion: We concluded that intrathecal magnesium as an adjuvant to hyperbaric Ropivacaine significantly prolonged both sensory blockade duration, post-operative pain-free interval without increasing motor blockade duration and the incidence of adverse effects.
Kuthiala G, Choudhary G. Ropivacaine: A review of its pharmacology and clinical use. Indian J Anaesth 2011;55:104-10.
Fettes PD, Hocking G, Peterson MK, Luck JF, Wildsmith JA. Comparison of plain and hyperbaric solutions of ropivacaine for spinal anaesthesia. Br J Anaesth 2005;94:107-11.
Singh AP, Kaur R, Gupta R, Kumari A. Intrathecal buprernorphine versus fentanyl as adjuvant to 0.75% ropivacaine in lower limb surgeries.J Anaesthesiol Clin Pharmacol 2016;32:229-33.
Campora E, Merlini L, Pace M, Bruzzone M, Luzzani M, Gottlieb A, et al. The incidence of narcotic-induced emesis. J Pain Symptom Manage 1991;6:428-30.
Haubold HA, Meltzer SJ. Spinal anaesthesia by magnesium sulphate. A report of seven operations performed under its influence. J Am Med Assoc 1906;46:647-50.
Herroeder S, Schönherr ME, De Hert SG, Hollmann MW. Magnesium-essentials for anaesthesiologists. Anaesthesiology 2011;114:971-93.
James MF. Magnesium: An emerging drug in anaesthesia. Br J Anaesth 2009;103:465-7.
Do SH. Magnesium a versatile drug for anaesthesiologists. Korean J Anesthesiol 2013;65:4-8.
Buvanendran A, McCarthy RJ, Kroin JS, Leong W, Perry P, Tuman KJ. Intrathecal magnesium prolongs fentanyl analgesia: A prospective, randomized, controlled trial. Ansesth Analg 2002;95:661-6.
Morrison AP, Hunter JM. Halp: Effect of intrathecal magnesium in the presence or absence of local anesthetic with and without lipophilic opioids: A systematic review and metanalysis. Br J Anesth 2013;13:702-12.
Ramirez JP, Trujillo SG, Alcantarilla C. Intrathecal magnesium as analgesic adjuvant for spinal anesthesia: A meta-analysis of randomized trials. Min Anestesiol 2013;79:667-78.
Kulkarni KR, Deshpande S, Namazi I, Singh SK, Kondilya K. A comparative evaluation of hyperbaric ropivacaine versus hyperbaric bupivacaine for elective surgery under spinal anesthesia. J Anesthesiol Clin Pharmacol 2014;30:238-42.
Jabalameli M, Pakzadmoghadam SH. Adding different doses of intrathecal magnesium sulphate for spinal anesthesia in the cesarean section: A prospective double blind randomized trial. Adv Biomed Res 2012;1:7.
Jabalameli M, Hamid S, Pakzadmoghadam: Adding different dose of intrathecal magnesium sulphate for spinal anesthesia for caesarean section. Adv Biomed Res 2012;1:1.
Shukla D, Verma A, Agarwal A, Pandey HD, Tyagi CH. Comparative study of intrathecal dexmedetomidine with intrathecal magnesium sulphate used as adjuvants to bupivacaine. J Anaesthesiol Clin Pharmacol 2011;27:495-9.
Khalil G, Janghorbani M, Sajedi P, Ahmadi G. Effects of adjunct intrathecal magnesium sulphate to bupivacaine for spinal anaesthesia: A randomized, double-blind trial in patients undergoing lower extremity surgery. J Anaesth 2011;25:892-7.
Unlugenc H, Ozalevli M, Gunduz M, Gunasti S, Urunsak F, Guler T, et al. Comparison of intrathecal magnesium, fentanyl, or placebo combined with bupivacaine 0.5% for parturients undergoing elective cesarean delivery. J Acta Anaesthesiol Scand 2009;53:346-53.
Woolf CJ, Thompson SW. The induction, maintenance of central sensitization is dependent on N-methyl-D-aspartic acid receptor activation implication for the treatment of post-injury pain hypersensitivity states. Pain 1991;44:293-9.
Ozalevli M, Cetin TO, Unlugenc H, Guler T, Isik G. The effect of adding intrathecal magnesium sulphate to bupivacaine-fentanyl spinal anaesthesia. Acta Anaesthesiol Scand 2005;49:1514-9.
Dayioglu H, Baykara ZN, Sabes A, Solak M, Toker K. Effects of adding magnesium to bupivacaine and fentanyl for spinal anaesthesia in knee arthroscopy. J Anaesth 2009;23:19-25.
Bamigbade TA, Langford RM, Blower AL. Pain control in day care surgery; tramadol compared to standard analgesia. Br J Anaesth 1998;80:558-9.
Ascher P, Norwak L. Electrophysiological studies of NMDA receptor. Trends Neurosciences 1987;10:284-8.
How to Cite
Copyright (c) 2021 Dr. Srinidhi Srikanth, Dr. Antony John Charles S. , Dr. Yasha Kamaeshar, Dr. Gayatri Mishra
This work is licensed under a Creative Commons Attribution 4.0 International License.
The publication is licensed under CC By and is open access. Copyright is with author and allowed to retain publishing rights without restrictions.